Back

Applicability and prognostic value of new proposed criteria for atrial cardiomyopathy in patients with heart failure

31 August 2026 (08:35 - 08:45)
Organised by: Logo
Congress Presentation Part of: Risk prediction and prognosis in heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Hiroki Uehara

Hokkaido University, Sapporo (Japan)

5 More presentations in this session

Presentation thumbnail
Beyond LVEF: morbidity burden (GMA) as the main predictor of mortality and outcomes in heart failure
Doctor H. Tizon Marcos (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Risk of dementia and mortality in patients with heart failure - a danish nationwide cohort study
Mr M. Blenkov (DK)
Abstract Slides Video
Presentation thumbnail
U-shaped association of HbA1c levels with incident cancer risk in patients with heart failure and type 2 diabetes mellitus
Miss Y. Qi (HK)
Abstract Slides Video
Presentation thumbnail
Heart failure clinic follow-up and outcomes after hospitalisation: a propensity-weighted cohort study
Mr J. Rolland (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Whole-genome landscapes of 1186 end stage heart failure patients undergoing heart transplantation
Doctor S. Xu (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Risk prediction and prognosis in heart failure
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 08:35 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of disproportionate left atrial myopathy in patients with heart failure
30 August 2026
thumbnail
Congress Presentation
Clinical impact of atrial fibrillation on cardiac parameters and long-term outcomes in patients with transthyretin amyloid cardiomyopathy in the era of disease-modifying therapy
28 August 2026
thumbnail
Congress Presentation
Update on atrial cardiomyopathy
31 August 2024
thumbnail
Congress Session
Aetiology, comorbidities, and outcomes in heart failure
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources